Intravenous Iron in Inflammatory Bowel Disease
Authors:
- Christoph GascheCGChristoph Gasche
- Stefanie KulniggSKStefanie Kulnigg
- 1 October 2006
- journal article
- Published by Elsevier in Seminars in Hematology
- Vol. 43, S18-S22
Abstract
No abstract availableThis publication has 48 references indexed in Scilit:
- Efficacy and tolerability of oral iron therapy in inflammatory bowel disease: a prospective, comparative trialAlimentary Pharmacology & Therapeutics, 2005
- Economic Burden of Patients with Anemia in Selected DiseasesValue in Health, 2005
- Oral ferrous fumarate or intravenous iron sucrose for patients with inflammatory bowel diseaseScandinavian Journal of Gastroenterology, 2005
- Hepcidin Regulates Cellular Iron Efflux by Binding to Ferroportin and Inducing Its InternalizationScience, 2004
- A Study for the Evaluation of Safety and Tolerability of Intravenous High-Dose Iron Sucrose in Patients with Iron Deficiency Anemia due to Gastrointestinal BleedingZeitschrift für Gastroenterologie, 2004
- Epidemiology of inflammatory bowel disease — methodological considerationsDigestive and Liver Disease, 2002
- Anemia in Crohn's diseaseDigestive Diseases and Sciences, 1994
- Serum Ferritin and the Assessment of Iron Deficiency in Rheumatoid ArthritisScandinavian Journal of Rheumatology, 1983
- LONG TERM NUTRITIONAL EFFECTS OF EXTENSIVE RESECTION OF THE SMALL INTESTINEAnz Journal of Surgery, 1982
- Cortisone in Ulcerative ColitisBMJ, 1955